These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 9425398
21. Pituitary-adrenocortical function in abdominal obesity of males: evidence for decreased 21-hydroxylase activity. Hautanen A, Adlercreutz H. J Steroid Biochem Mol Biol; 1996 Apr; 58(1):123-33. PubMed ID: 8809194 [Abstract] [Full Text] [Related]
22. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma. Fernández-Real JM, Engel WR, Simó R, Salinas I, Webb SM. Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847 [Abstract] [Full Text] [Related]
23. Visfatin levels do not change after the oral glucose tolerance test and after a dexamethasone-induced increase in insulin resistance in humans. Marcinkowska M, Lewandowski KC, Lewiński A, Bieńkiewicz M, Basińska-Lewandowska M, Salata I, Randeva HS. Endokrynol Pol; 2007 Jul; 58(3):188-94. PubMed ID: 17940983 [Abstract] [Full Text] [Related]
24. Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Maccario M, Ramunni J, Oleandri SE, Procopio M, Grottoli S, Rossetto R, Savio P, Aimaretti G, Camanni F, Ghigo E. Int J Obes Relat Metab Disord; 1999 Jun; 23(6):612-8. PubMed ID: 10411234 [Abstract] [Full Text] [Related]
25. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults. al-Shoumer KA, Beshyah SA, Niththyananthan R, Johnston DG. Clin Endocrinol (Oxf); 1995 Jan; 42(1):85-90. PubMed ID: 7889636 [Abstract] [Full Text] [Related]
27. Retinol-binding protein 4 (RBP-4) levels do not change after oral glucose tolerance test and after dexamethasone, but correlate with some indices of insulin resistance in humans. Lewandowski KC, Basinska-Lewandowska M, Bieńkiewicz M, Randeva HS, Lewiński A. Endokrynol Pol; 2008 Jan; 59(4):305-11. PubMed ID: 18777500 [Abstract] [Full Text] [Related]
28. Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus. Gaillard TR, Schuster DP, Osei K. Ethn Dis; 1998 Jan; 8(3):319-30. PubMed ID: 9926902 [Abstract] [Full Text] [Related]
29. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA, Katsilambros N. Metabolism; 1999 Oct; 48(10):1332-5. PubMed ID: 10535400 [Abstract] [Full Text] [Related]
30. Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study. Fernandez-Real JM, Pugeat M, Grasa M, Broch M, Vendrell J, Brun J, Ricart W. J Clin Endocrinol Metab; 2002 Oct; 87(10):4686-90. PubMed ID: 12364459 [Abstract] [Full Text] [Related]
31. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness. Amoah AG, Owusu SK, Schuster DP, Osei K. S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171 [Abstract] [Full Text] [Related]
32. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Rask E, Olsson T, Söderberg S, Holst Jj Jj, Tura A, Pacini G, Ahrén B. Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768 [Abstract] [Full Text] [Related]
34. Relationships of obesity indices to serum insulin and lipoproteins in relatives of black patients with noninsulin-dependent diabetes mellitus (NIDDM). Osei K, Cottrell DA, Bossetti B. Int J Obes; 1991 Jul; 15(7):441-51. PubMed ID: 1894421 [Abstract] [Full Text] [Related]
35. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives. Feldstein CA, Renauld A, Akopian M, Olivieri AO, Garrido D. J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552 [Abstract] [Full Text] [Related]
36. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Holte J, Bergh T, Berne C, Lithell H. Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457 [Abstract] [Full Text] [Related]
37. Food-induced cortisol secretion in relation to anthropometric, metabolic and haemodynamic variables in men. Rosmond R, Holm G, Björntorp P. Int J Obes Relat Metab Disord; 2000 Apr; 24(4):416-22. PubMed ID: 10805497 [Abstract] [Full Text] [Related]
38. Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension. Maccario M, Oleandri SE, Avogadri E, Rossetto R, Grottoli S, Procopio M, Camanni F, Ghigo E. J Endocrinol Invest; 1998 Jan; 21(1):56-63. PubMed ID: 9633024 [Abstract] [Full Text] [Related]
39. Fasting gall bladder volume and lithogenicity in relation to glucose tolerance, total and intra-abdominal fat masses in obese non-diabetic subjects. Hendel HW, Højgaard L, Andersen T, Pedersen BH, Paloheimo LI, Rehfeld JF, Gotfredsen A, Rasmussen MH. Int J Obes Relat Metab Disord; 1998 Apr; 22(4):294-302. PubMed ID: 9578233 [Abstract] [Full Text] [Related]
40. Comparison of insulin sensitivity indices calculated from standard 3-sampled and frequently sampled oral glucose tolerance test. Penesova A, Radikova Z. Endocr Regul; 2004 Dec; 38(4):167-71. PubMed ID: 15841797 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]